While semaglutide is FDA approved and generally well tolerated, side effects may include nausea, digestive changes, headache, fatigue, dizziness, or low blood sugar
Rosenblum, J
A structured plan for life after medication to prevent weight regain Research from the STEP 1 extension trial showed that people who stopped semaglutide regained roughly two-thirds of the weight theyd lost within a year
The findings are suggestive of social interactions being more rewarding for juveniles
Auxin-mediated molecular mechanisms of heavy metal and metalloid stress regulation in plants
Abbreviations ASCVD: Atherosclerotic cardiovascular disease CHD: Coronary heart disease CI: Confidence interval CVD: Cardiovascular disease CVOT: Cardiovascular outcome trial DPP-4i: Dipeptidyl peptidase-4 inhibitor GLP-1: Glucagon-like peptide 1 GLP-1R: Glucagon-like peptide 1 receptor HbA1c: Glycated haemoglobin HR: Hazard ratio LDL: Low-density lipoprotein MACEs: Major cardiovascular events NO: Nitric oxide OR: Odds ratio PIONEER: Peptide Innovation for Early Diabetes Treatment ROS: Reactive oxygen species SC: Subcutaneous SNAC: Sodium N -[8-(2-hydroxybenzoyl)amino] caprylate TAGs: Triacylglycerols TGs: Triglycerides T2DM: Type 2 diabetes mellitus VLDL: Very-low-density lipoprotein References Litwak L, Goh SY, Hussein Z, Malek R, Prusty V, Khamseh ME
